Payment overview · 2025
General Payments
$168.56
9 reported records · 4 companies
Healthcare provider profile · identity verified
Charles Pruitt, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · MAGEE, MS · NPI 1700978889
Verified facts
What the public records show
CMS Open Payments records show Charles Pruitt, M.D. received $168.56 in general payments during 2025 across 9 reported records.
Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 46.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 42 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Lumigan by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Synthroid by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 260 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $77.77 | 46.1% | 4 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $57.82 | 34.3% | 3 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $19.78 | 11.7% | 1 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $13.19 | 7.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $168.56 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $57.82 | 3 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $57.82 | 3 | 2025 |
Source payment records
|
|||||
| OFEV Normalized: ofev |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $44.92 | 2 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $32.85 | 2 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $19.78 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $13.19 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 260 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
21 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
42 | 15 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
260 | 39 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 626 | 125 |
| Amlodipine Besylate | Amlodipine Besylate | 614 | 130 |
| Atorvastatin Calcium | Atorvastatin Calcium | 613 | 132 |
| Hydrochlorothiazide | Hydrochlorothiazide | 547 | 135 |
| Omeprazole | Omeprazole | 517 | 111 |
| Levothyroxine Sodium | Levothyroxine Sodium | 476 | 86 |
| Eliquis | Apixaban | 444 | 45 |
| Furosemide | Furosemide | 440 | 109 |
| Lisinopril | Lisinopril | 418 | 92 |
| Potassium Chloride | Potassium Chloride | 407 | 84 |
| Metformin Hcl | Metformin Hcl | 404 | 95 |
| Sertraline Hcl | Sertraline Hcl | 314 | 66 |
| Pantoprazole Sodium | Pantoprazole Sodium | 301 | 68 |
| Losartan Potassium | Losartan Potassium | 286 | 70 |
| Meloxicam | Meloxicam | 270 | 75 |
| Metoprolol Tartrate | Metoprolol Tartrate | 269 | 53 |
| Metoprolol Succinate | Metoprolol Succinate | 265 | 59 |
| Jardiance | Empagliflozin | 260 | 39 |
| Zolpidem Tartrate | Zolpidem Tartrate | 256 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 242 | 53 |
| Trazodone Hcl | Trazodone Hcl | 241 | 46 |
| Pravastatin Sodium | Pravastatin Sodium | 232 | 43 |
| Tramadol Hcl | Tramadol Hcl | 226 | 56 |
| Allopurinol | Allopurinol | 204 | 40 |
| Famotidine | Famotidine | 195 | 42 |
| Donepezil Hcl | Donepezil Hcl | 193 | 37 |
| Clopidogrel | Clopidogrel Bisulfate | 188 | 47 |
| Cephalexin | Cephalexin | 185 | 123 |
| Buspirone Hcl | Buspirone Hcl | 172 | 38 |
| Simvastatin | Simvastatin | 164 | 30 |
| Prednisone | Prednisone | 143 | 42 |
| Citalopram Hbr | Citalopram Hydrobromide | 130 | 31 |
| Duloxetine Hcl | Duloxetine Hcl | 129 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 128 | 38 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 125 | 33 |
| Azithromycin | Azithromycin | 120 | 91 |
| Mirtazapine | Mirtazapine | 120 | 16 |
| Ozempic | Semaglutide | 119 | 19 |
| Montelukast Sodium | Montelukast Sodium | 116 | 32 |
| Glipizide | Glipizide | 115 | 25 |
| Carvedilol | Carvedilol | 114 | 26 |
| Glimepiride | Glimepiride | 114 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 109 | 32 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 105 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 104 | 26 |
| Memantine Hcl | Memantine Hcl | 102 | 15 |
| Sucralfate | Sucralfate | 101 | 21 |
| Fluconazole | Fluconazole | 100 | 47 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 98 | 15 |
| Risperidone | Risperidone | 98 | 16 |
| Dutasteride | Dutasteride | 97 | 17 |
| Finasteride | Finasteride | 95 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 89 | 16 |
| Atenolol | Atenolol | 84 | 16 |
| Methocarbamol | Methocarbamol | 83 | 31 |
| Myrbetriq | Mirabegron | 83 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 82 | 30 |
| Warfarin Sodium | Warfarin Sodium | 82 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 81 | 17 |
| Glipizide Er | Glipizide | 78 | 15 |
| Ezetimibe | Ezetimibe | 76 | 11 |
| Valsartan | Valsartan | 75 | 12 |
| Estradiol | Estradiol | 69 | 19 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 66 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 66 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 66 | 16 |
| Diltiazem 24hr Er | Diltiazem Hcl | 65 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 64 | 18 |
| Acyclovir | Acyclovir | 62 | 22 |
| Farxiga | Dapagliflozin Propanediol | 62 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 61 | 24 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 60 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 59 | 14 |
| Spironolactone | Spironolactone | 58 | 11 |
| Trulicity | Dulaglutide | 58 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 57 | suppressed |
| Nitroglycerin | Nitroglycerin | 57 | 31 |
| Mupirocin | Mupirocin | 56 | 34 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 55 | 31 |
| Meclizine Hcl | Meclizine Hcl | 55 | 27 |
| Nystatin | Nystatin | 55 | 24 |
| Propranolol Hcl | Propranolol Hcl | 55 | 15 |
| Colchicine | Colchicine | 54 | 13 |
| Levetiracetam | Levetiracetam | 54 | suppressed |
| Ranolazine Er | Ranolazine | 54 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 54 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 52 | 15 |
| Aripiprazole | Aripiprazole | 52 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 52 | 15 |
| Baclofen | Baclofen | 51 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 50 | 36 |
| Penicillin V Potassium | Penicillin V Potassium | 50 | 19 |
| Amoxicillin | Amoxicillin | 49 | 34 |
| Diltiazem Hcl | Diltiazem Hcl | 49 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 48 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 48 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 44 | suppressed |
| Celecoxib | Celecoxib | 44 | 16 |
| Clonidine Hcl | Clonidine Hcl | 44 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 44 | 20 |
| Metformin Hcl Er | Metformin Hcl | 44 | 13 |
| Xarelto | Rivaroxaban | 44 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 42 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 42 | 11 |
| Linzess | Linaclotide | 42 | 15 |
| Lovastatin | Lovastatin | 42 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 40 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 40 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 40 | 36 |
| Ibuprofen | Ibuprofen | 39 | 18 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 38 | 19 |
| Hydrocortisone | Hydrocortisone | 38 | suppressed |
| Januvia | Sitagliptin Phosphate | 37 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 36 | 25 |
| Promethazine Hcl | Promethazine Hcl | 36 | 14 |
| Metoclopramide Hcl | Metoclopramide Hcl | 35 | suppressed |
| Pregabalin | Pregabalin | 35 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 35 | suppressed |
| Naproxen | Naproxen | 34 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 33 | suppressed |
| Digoxin | Digoxin | 33 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | suppressed |
| Nifedipine Er | Nifedipine | 32 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Synthroid | Levothyroxine Sodium | 32 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 31 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 31 | suppressed |
| Ramipril | Ramipril | 31 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 30 | 16 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 30 | 15 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 30 | suppressed |
| Clonazepam | Clonazepam | 29 | suppressed |
| Olanzapine | Olanzapine | 29 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | suppressed |
| Tradjenta | Linagliptin | 27 | suppressed |
| Carbamazepine | Carbamazepine | 26 | suppressed |
| Lactulose | Lactulose | 26 | suppressed |
| Methylprednisolone | Methylprednisolone | 26 | 22 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Cefdinir | Cefdinir | 25 | 16 |
| Metronidazole | Metronidazole | 25 | suppressed |
| Pentoxifylline | Pentoxifylline | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | suppressed |
| Gemfibrozil | Gemfibrozil | 24 | suppressed |
| Mounjaro | Tirzepatide | 24 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 22 | suppressed |
| Bupropion Xl | Bupropion Hcl | 22 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 22 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 15 |
| Creon | Lipase/Protease/Amylase | 21 | suppressed |
| Eszopiclone | Eszopiclone | 21 | 11 |
| Indomethacin | Indomethacin | 21 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 21 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 20 | 12 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 20 | 13 |
| Rivastigmine | Rivastigmine Tartrate | 20 | suppressed |
| Topiramate | Topiramate | 20 | suppressed |
| Cilostazol | Cilostazol | 19 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 19 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 19 | suppressed |
| Novolin R | Insulin Regular, Human | 19 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 19 | suppressed |
| Lorazepam | Lorazepam | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Latanoprost | Latanoprost | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 17 | suppressed |
| Clonidine | Clonidine | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Haloperidol | Haloperidol | 16 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 16 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 15 | 11 |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Lumigan | Bimatoprost | 15 | suppressed |
| Metolazone | Metolazone | 15 | suppressed |
| Timolol Maleate | Timolol Maleate | 15 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Epinephrine | Epinephrine | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 14 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Enulose | Lactulose | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 13 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Trandolapril | Trandolapril | 13 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 13 | suppressed |
| Chlorzoxazone | Chlorzoxazone | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Paroxetine Er | Paroxetine Hcl | 12 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 12 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 12 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Constulose | Lactulose | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Desipramine Hcl | Desipramine Hcl | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 11 | suppressed |
| Minoxidil | Minoxidil | 11 | suppressed |
| Ursodiol | Ursodiol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $168.56 · 9 records | Boehringer Ingelheim Pharmaceuticals, Inc. | AUSTEDO XR, Auvelity, JARDIANCE, OFEV, QULIPTA, UBRELVY | 5 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error